Can omega 3 (fatty acids) supplements help manage symptoms of uterine fibroids?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Omega-3 Supplements for Managing Uterine Fibroid Symptoms

Omega-3 fatty acids may help manage some symptoms of uterine fibroids, with evidence suggesting they can reduce inflammation and potentially limit fibroid growth, though they are not considered a first-line treatment option. 1

Mechanism of Action and Evidence

  • Omega-3 fatty acids can modify the lipid profile and membrane architecture of leiomyoma cells, potentially reducing expression of genes involved in mechanical signaling and lipid accumulation in fibroid cells 2
  • Erythrocyte membrane levels of omega-3 polyunsaturated fatty acids have been inversely associated with the likelihood of fibroids (OR for highest vs lowest tertile, 0.41; 95% CI 0.19-0.89) 1
  • Omega-3 supplements have demonstrated efficacy in reducing pain intensity in primary dysmenorrhea, which could be beneficial for fibroid-related pain symptoms 3

Current Treatment Guidelines for Uterine Fibroids

First-Line Medical Management

  • NSAIDs and estrogen-progestin oral contraceptive pills are recommended as first-line medical treatments for reducing bleeding symptoms associated with uterine fibroids 4
  • Progestin-containing intrauterine devices (IUDs) are effective for long-term management of fibroid-related bleeding 4
  • Tranexamic acid is an effective non-hormonal alternative for reducing bleeding symptoms in patients who cannot use hormonal options 4

Second-Line Medical Options

  • GnRH agonists and oral GnRH antagonists can reduce bleeding symptoms and significantly decrease fibroid volume by 18-30% 4
  • Combination treatment with low doses of estrogen and progestin (add-back therapy) can mitigate side effects of GnRH modulators 4

Potential Role of Omega-3 Supplements

  • While not mentioned in current fibroid management guidelines, omega-3 supplements may serve as an adjunctive therapy based on emerging research 2, 1
  • Laboratory studies show omega-3 fatty acids can remodel membrane architecture and downregulate expression of genes involved in fibroid growth 2
  • Population studies suggest an inverse relationship between omega-3 levels and fibroid risk 1

Practical Recommendations

  • For patients with mild fibroid symptoms seeking complementary approaches, omega-3 supplements may be considered as an adjunct to standard medical therapies 2, 1
  • Dosing guidance is limited, but studies examining omega-3 for dysmenorrhea used daily supplementation for at least 3 months to observe benefits 3
  • Patients should be advised that omega-3 supplements are not a replacement for established treatments such as hormonal therapies, NSAIDs, or surgical interventions when indicated 5, 4

Caveats and Limitations

  • Current fibroid management guidelines from the American College of Radiology do not specifically mention omega-3 supplements as a recommended treatment 5
  • The evidence for omega-3 benefits in fibroid management comes primarily from laboratory studies and observational research rather than large clinical trials 2, 1
  • Patients approaching menopause may experience natural reduction in fibroid symptoms regardless of intervention, as fibroid-associated symptoms typically decline in postmenopausal patients 5

Other Dietary Considerations

  • Vitamin D deficiency has been strongly linked to fibroid formation, making it a potentially important supplement for patients with fibroids 6
  • A diet rich in fruits and vegetables (sources of carotenoids, polyphenols, quercetin) may be beneficial for patients with uterine fibroids 6
  • High levels of trans fatty acids have been associated with increased odds of fibroids (OR for highest tertile, 3.33; 95% CI 1.50-7.38) 1

References

Research

Effect of omega-3 fatty acids on intensity of primary dysmenorrhea.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2012

Guideline

Treatment Options for Symptomatic Uterine Fibroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.